Skip to main content

Animations

MJFF Publications

7101 - 7110 of 8808 Results
Title
Year
  • Year
  • 2018
  • 2024
  • 2024
  • 2011
  • 2024
  • 2024
  • 2025
  • 2021
  • 2021
  • 2024
  • Summary Details
    OPEN
    Title: Investigation of serotonergic Parkinson's disease-related covariance pattern using [11C]-DASB/PET
    Journal Name: NeuroImage: Clinical
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.nicl.2018.05.022
    Citation Count: 27
  • Summary Details
    OPEN
    Title: Biallelic NDUFA13 variants lead to a neurodevelopmental phenotype with gradual neurological impairment
    Journal Name: Brain Communications
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by, cc-by
    DOI - Digital Object Identifier: 10.1093/braincomms/fcae453
    Citation Count: 2
  • Summary Details
    RESTRICTED
    Title: A molecular glue for PRKN/parkin
    Journal Name: Autophagy
    Publisher: Informa UK Limited
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1080/15548627.2024.2443232
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Lrrk2 p.Q1111H substitution and Parkinson’s disease in Latin America
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2011.05.003
    Citation Count: 17
  • Summary Details
    RESTRICTED
    Title: Bacteroides acidifaciens: Linking dietary fiber to liver health
    Journal Name: Cell Metabolism
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.cmet.2024.08.002
    Citation Count: 3
  • Summary Details
    OPEN
    Title: α‐Synuclein Pathology in PRKN‐Linked Parkinson's Disease: New Insights from a Blood‐Based Seed Amplification Assay
    Journal Name: Annals of Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/ana.26917
    Citation Count: 18
  • Summary Details
    OPEN
    Title: Copper supplementation mitigates Parkinson-like wild-type SOD1 pathology and nigrostriatal degeneration in a novel mouse model
    Journal Name: Acta Neuropathologica Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s40478-025-02048-2
    Citation Count: 0
  • Summary Details
    RESTRICTED
    Title: Cerebrospinal fluid hemoglobin levels as markers of blood contamination: relevance for α-synuclein measurement
    Journal Name: Clinical Chemistry and Laboratory Medicine (CCLM)
    Publisher: Walter de Gruyter GmbH
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1515/cclm-2020-1521
    Citation Count: 6
  • Summary Details
    OPEN
    Title: Preformed fibrils generated from mouse alpha-synuclein produce more inclusion pathology in rats than fibrils generated from rat alpha-synuclein
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.06.010
    Citation Count: 16
  • Summary Details
    OPEN
    Title: Predictors of stress resilience in Parkinson’s disease and associations with symptom progression
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-024-00692-4
    Citation Count: 11
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.